Vaxxinity, Inc.

Vaxxinity, Inc. financial statements

Vaxxinity, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2023

RevenueUSD 0EODHD
Net income−USD 56.93KEODHD
Cash and equivalentsUSD 4.93MEODHD
Total debtUSD 15.17MEODHD

Vaxxinity, Inc. financials on 6ix · Vaxxinity, Inc. on 6ix